social media

Pharma and Social Media; Can They Coexist

May 8, 2009 By Theresa Smith

For nearly five years (2003-2008) I was the Public Relations counsel for a provider of predictive analytics and reporting software solutions that counted many of the world’s top pharmaceutical companies as its customers. My client’s software enabled life science and pharmaceutical researchers and analysts in drug discovery, development and clinical trials to more efficiently and accurately mine their data and utilize predictive analytics for their analysis. The work these researchers and analysts are doing is exciting and newsworthy.

However, there were many obstacles we ran into in getting the news out about the progress and innovation these researchers were achieving. The biggest hurdle was not with the individual researchers and analysts, but instead with the pharmaceutical companies’ corporate public relations and legal departments. So this week I was intrigued to see on Twitter that the April issue of Pharma Marketing News was “all about pharma & social media.”

photo credit: Sebastian Bergmann

John Mack sets the stage for the issue by writing in the article “Social Media Opportunity or Nightmare” :

“Michelangelo’s nightmarish painting Last Judgement includes the image of a poor soul being dragged down to Hell by the devil’s agents. That image often comes to mind when I hear proponents of social media trying to persuade pharma marketers to just “dip their toe” in the social media waters. The other image I see is a shark lurking just below the water’s surface!”

Mack went on to argue:

“Many pharma marketers within drug companies and within agencies that work for drug companies are trying to move the needle forward to develop guidelines that the industry can follow. So far, however, they have left patients, physicians and other stakeholders out of the discussion. They have forgotten that patient empowerment built the very social networks that they wish to engage in. Personally, I believe pharmaceutical companies need to become truly patient-centric companies BEFORE they can even consider engaging in social media.”

Mack’s article reminded me of Jeremy Owyang’s blog “Troubled, Some Pharmaceuticals Turn a Blind Eye to the Blogosphere” from June 14, 2008 . In Owyang’s blog he reports:

“While this may not hold true for every pharmaceutical company, I recently met one who had banned it’s employees from monitoring blogs, social media and the online conversation.
[Why did this pharma company ban their employees to monitor blogs? If a patient complained about a treatment or medicine having ill-effects, then the pharma would would be liable to take action]. Responding to every customer can be very, very costly, considering how many people may be talking about medicines, often anonymously in online forums.”

It’s exciting to see that the pharmaceutical industry is now realizing it needs to be discussing and establishing guidelines for social media. Will pharma and social media be able to coexist? What do you think?

Filed Under: marketing, public relations, social media Tagged With: Jeremy Owyang, marketing, PathwayPR, Pharma Marketing News, pharmaceutical companies, public relations, social media

Ashton Kutcher Gets Social Media — Do You?

April 19, 2009 By Theresa Smith

By now– unless you have been living under a rock for the last week without any Internet connection and have taken an oath against listening to any news—you have heard about how Ashton Kutcher challenged CNN to see who could get to one million followers first on Twitter. Kutcher won. But maybe his challenge means we all won.

On Friday, April 17, 2009 after winning his challenge, Kutcher told Oprah that he believes that “We’re at a place now with social media where a single person’s voice can be as powerful as an entire news network — that is the power of the social web.”

He went on to say that as a celebrity his life “somewhat on display anyway, and not always by choice… so instead of them publishing pictures and videos I don’t like, I can publish pictures and video of myself… that I’m happy with. If there’s some sort of fallacy that’s out in some magazine or that some blogger has written about, you can respond to it, and you can actually respond to it in a genuine way, directly with your fans.”

In an article for The Huffington Post titled “Changing the Face of Media: Kutcher vs CNN” Andrew Cherwenka, vice president of business development at trapeze.com wrote:

Kutcher gets new media. His livecast during the race – a continuous live video stream over the internet – was an engaged conversation. He read followers’ tweets on air, asked questions, and actively engaged his audience using Twitter. He linked us to YouTube clips and his chosen charity, www.malarianomore.org. He advanced his next cause, fighting human trafficking.

At the end of the day, Kutcher has been able to raise almost one million dollars for Malaria No More and maybe he also showed the power of social media to the non-believers out there. What do you think?

Filed Under: public relations, social media, twitter Tagged With: Andrew Cherwenka, Ashton Kutcher, CNN, PathwayPR, public relations, social media, twitter

Categories

Recent Posts

PathwayPR Tweets

So, what started as a quick question, ended up being a fun journey around the world courtesy of the Tweeple Group on LinkedIn. Now, for the download.

What are you using to manage your Twitter account?

Categories

Recent Posts

Tags

PathwayPR Tweets

Secondary Sidebar Widget Area